Effects of Osthole on Inflammatory Gene Expression and Cytokine Secretion in Histamine-Induced Inflammation in the Caco-2 Cell Line

被引:10
作者
Kordulewska, Natalia K. [1 ]
Topa, Justyna [2 ]
Rozmus, Dominika [1 ]
Jarmolowska, Beata [1 ]
机构
[1] Univ Warmia & Mazury, Fac Biol & Biotechnol, Dept Biochem, PL-10719 Olsztyn, Poland
[2] Med Univ Gdansk, Intercollegiate Fac Biotechnol, Lab Translat Oncol, PL-80211 Gdansk, Poland
关键词
pro-inflammatory cytokine; anti-inflammatory cytokine; interleukin; gene expression; inflammatory intestinal disease; NF-KAPPA-B; INTESTINAL EPITHELIAL-CELLS; ALLERGIC RHINITIS; INTERFERON-GAMMA; UP-REGULATION; FATTY LIVER; FEXOFENADINE; MODEL; PROLIFERATION; ANTIOXIDANT;
D O I
10.3390/ijms222413634
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hyperactivity of the immune system in the gastrointestinal tract leads to the development of chronic, inflammation-associated disorders. Such diseases, including inflammatory bowel disease, are not completely curable, but the specific line of treatment may reduce its symptoms. However, the response to treatment varies among patients, creating a necessity to uncover the pathophysiological basis of immune-mediated diseases and apply novel therapeutic strategies. The present study describes the anti-inflammatory properties of osthole during histamine-induced inflammation in the intestinal Caco-2 cell line. Osthole reduced the secretion of cytokines (CKs) and the expression level of inflammation-associated genes, which were increased after a histamine treatment. We have shown that the secretion of pro-inflammatory CKs (IL-1 beta, IL-6, IL-8, and TNF-alpha) during inflammation may be mediated by NF kappa B, and, after osthole treatment, this signaling pathway was disrupted. Our results suggest a possible role for osthole in the protection against inflammation in the gastrointestinal tract; thus, osthole may be considered as an anti-inflammatory modulator.
引用
收藏
页数:17
相关论文
共 83 条
  • [1] Abosharaf Hamed A., 2020, Biotechnology Reports, V28, pe00531, DOI 10.1016/j.btre.2020.e00531
  • [2] Angelis ID., 2011, Curr Protoc Toxicol, DOI DOI 10.1002/0471140856.TX2006S47
  • [3] Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
    Atreya, Raja
    Neurath, Markus F.
    Siegmund, Britta
    [J]. FRONTIERS IN MEDICINE, 2020, 7
  • [4] IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS
    AUPHAN, N
    DIDONATO, JA
    ROSETTE, C
    HELMBERG, A
    KARIN, M
    [J]. SCIENCE, 1995, 270 (5234) : 286 - 290
  • [5] Histamine H1-receptor activation of nuclear factor-κB:: Roles for Gβγ- and Gαq/11-subunits in constitutive and agonist-mediated signaling
    Bakker, RA
    Schoonus, SBJ
    Smit, MJ
    Timmerman, H
    Leurs, R
    [J]. MOLECULAR PHARMACOLOGY, 2001, 60 (05) : 1133 - 1142
  • [6] Biological Therapies in Immune-Mediated Inflammatory Diseases: Can Biosimilars Reduce Access Inequities?
    Baumgart, Daniel C.
    Misery, Laurent
    Naeyaert, Sue
    Taylor, Peter C.
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [7] Interplay Between NLRP3 Inflammasome and Autophagy
    Biasizzo, Monika
    Kopitar-Jerala, Natasa
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [8] Inflammasomes: mechanism of assembly, regulation and signalling
    Broz, Petr
    Dixit, Vishva M.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2016, 16 (07) : 407 - 420
  • [9] Inflammatory Bowel Disease: New Insights into the Interplay between Environmental Factors and PPARγ
    Caioni, Giulia
    Viscido, Angelo
    d'Angelo, Michele
    Panella, Gloria
    Castelli, Vanessa
    Merola, Carmine
    Frieri, Giuseppe
    Latella, Giovanni
    Cimini, Annamaria
    Benedetti, Elisabetta
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (03) : 1 - 19
  • [10] Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy
    Capuron, L
    Raison, CL
    Musselman, DL
    Lawson, DH
    Nemeroff, CB
    Miller, AH
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (07) : 1342 - 1345